TITLE

Antihypertensive drug treatment changes in the general population: the colaus study

AUTHOR(S)
Christe, Vanessa; Waeber, Gérard; Vollenweider, Peter; Marques-vidal, Pedro
PUB. DATE
March 2014
SOURCE
BMC Pharmacology & Toxicology;2014, Vol. 15 Issue 1, p20
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Changes in antihypertensive drug treatment are paramount in the adequate management of patients with hypertension, still, there is little information regarding changes in antihypertensive drug treatment in Switzerland. Our aim was to assess those changes and associated factors in a population-based, prospective study. Methods: Data from the population-based, CoLaus study, conducted among subjects initially aged 35–75 years and living in Lausanne, Switzerland. 772 hypertensive subjects (371 women) were followed for a median of 5.4 years. Data Subjects were defined as continuers (no change), switchers (one antihypertensive class replaced by another), combiners (one antihypertensive class added) and discontinuers (stopped treatment). The distribution and the factors associated with changes in antihypertensive drug treatment were assessed. Results: During the study period, the prescription of diuretics decreased and of ARBs increased: at baseline, diuretics were taken by 46.9% of patients; angiotensin receptor blockers (ARB) by 44.7%, angiotensin converting enzyme inhibitors (ACEI) by 28.8%, beta-blockers (BB) by 28.0%, calcium channel blockers (CCB) by 18.9% and other antihypertensive drugs by 0.3%. At follow-up (approximately 5 years later), their corresponding percentages were 42.8%, 51.7%, 25.5%, 33.0% 20.7% and 1.0%. Among all participants, 54.4% (95% confidence interval: 50.8-58.0) were continuers, 26.9% (23.8-30.2) combiners, 12.7% (10.4-15.3) switchers and 6.0% (4.4-7.9) discontinuers. Combiners had higher systolic blood pressure values at baseline than the other groups (p < 0.05). Almost one third (30.6%) of switchers and 29.3% of combiners improved their blood pressure status at follow-up, versus 18.8% of continuers and 8.7% of discontinuers (p < 0.001). Conversely, almost one third (28.3%) of discontinuers became hypertensive (systolic ≥140 mm Hg or diastolic ≥90 mm Hg), vs. 22.1% of continuers, 16.3% of switchers and 11.5% of combiners (p < 0.001). Multivariate analysis showed baseline uncontrolled hypertension, ARBs, drug regimen (monotherapy/ polytherapy) and overweight/obesity to be associated with changes in antihypertensive therapy. Conclusion: In Switzerland, ARBs have replaced diuretics as the most commonly prescribed antihypertensive drug. Uncontrolled hypertension, ARBs, drug regimen (monotherapy or polytherapy) and overweight/obesity are associated with changes in antihypertensive treatment.
ACCESSION #
110347121

 

Related Articles

  • Withdrawing antihypertensive drugs in the elderly. Pinkowish, Mary Desmond // Patient Care;Dec2002, Vol. 36 Issue 14, p86 

    Presents the results of study on the withdrawal of antihypertensive drugs in elderly patients. Factors associated with normotension on withdrawal of antihypertensive drugs; Predictors of being hypertensive without treatment; Recommendations for elderly patients withdrawing from antihypertensive...

  • Antihypertensive Use: Frequency/Severity of Side Effects Increases Absenteeism.  // Kidney;May/Jun99, Vol. 8 Issue 3, p130 

    Discusses the abstract of a study entitled `Follow-up study of the use of antihypertensive drug treatment and of the population treated,' by E.F. Boumendil, C. Mugnier, published in the 1998 'American Journal of Hypertension.'

  • Efficacy and Tolerability of Amlodipine in the General Practice Treatment of Essential Hypertension in an Asian Multinational Population. Taylor, S.H.; Chen, M-F.; Lee, S.J.K.; Koanantakul, B.; Zhu, J.R.; Santoso, T.; Sy, R.G.; Tai, Y.T. // Clinical Drug Investigation;1998, Vol. 16 Issue 3, p177 

    Objective: To evaluate the efficacy and tolerability of once-daily amlodipine (Pfizer Pharmaceuticals Inc.) alone or in combination with other antihypertensive drugs in an Asian population with essential hypertension. Patients: An open study was undertaken in 165 male and 158 female patients...

  • Do antihypertensive drugs precipitate diabetes in predisposed men? Skarfors, Einar T.; Lithell, Hans O.; Selinus, Ingemar; Aberg, Hans // BMJ: British Medical Journal (International Edition);4/29/89, Vol. 298 Issue 6681, p1147 

    Evaluates the influence of antihypertensive treatment and metabolic characteristics on the development of diabetes mellitus in middle aged men. Difference on diabetes incidence following hypertensive treatment; Concern on metabolic effects of antihypertensive drugs; Description on changes in...

  • Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs. Anderson, Gail D.; Carr, Darcy B. // Clinical Pharmacokinetics;2009, Vol. 48 Issue 3, p159 

    In the US, approximately 12% of women have hypertension during their pregnancy. Antihypertensive drugs are often given to lower maternal blood pressure in those with severe hypertension to prevent stroke and hypertensive crises. There is no conclusive evidence that antihypertensive treatment is...

  • Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study.  // BMC Public Health;2011, Vol. 11 Issue 1, p733 

    The article presents the findings of a population-based CoLaus study which reports that hyperhomocysteinemia is independently associated with albuminuria. It examines whether homocysteine and uric acid are associated with glomerular filtration rate (GFR) and albuminuria independently of each...

  • Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Caro, J. Jaime; Speckman, Jeanne L.; Salas, Maribel; Raggio, Gabriel; Jackson, Joseph D. // CMAJ: Canadian Medical Association Journal;1/12/99, Vol. 160 Issue 1, p41 

    Presents a medical study that examines the relation of persistence with treatment to the class of antihypertensive drug initially chosen. Methods; Results; Conclusions.

  • Antihypertensive Treatment after Stroke and All-Cause Mortality – An Analysis of the General Practitioner Research Database (GPRD). Toschke, André Michael; Wolfe, Charles D. A.; Heuschmann, Peter Ulrich; Rudd, Anthony G.; Gulliford, Martin // Cerebrovascular Diseases;Aug2009, Vol. 28 Issue 2, p105 

    Background: Randomised controlled trials have shown a beneficial effect of antihypertensive treatment on stroke recurrence. The effect of antihypertensive treatment on survival and recurrence in an unselected sample of the general population, using the General Practice Research Database, was...

  • Gender does not affect antihypertensive treatment outcomes.  // Geriatrics;Jul97, Vol. 52 Issue 7, p29 

    Focuses on the result of the study to determine the effect of antihypertensive treatment on men and women. How both men and women receive equal cardiovascular benefit from antihypertensive drug; Relative risk prediction that attribute to treatment in both sexes.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics